Sovilnesib
2-(6-azaspiro[2.5]octan-6-yl)-N-[2-(4,4-difluoropiperidin-1-yl)-6-methylpyrimidin-4-yl]-4-(2-hydroxyethylsulfonylamino)benzamide
Molecular Identity
Sovilnesib
2-(6-azaspiro[2.5]octan-6-yl)-N-[2-(4,4-difluoropiperidin-1-yl)-6-methylpyrimidin-4-yl]-4-(2-hydroxyethylsulfonylamino)benzamide
PubChem CID: 148163435
2D Structure
Properties
C26H34F2N6O4S
Molecular Formula
564.60
Molecular Weight
g/mol
564.2330
Exact Mass
Da
3.8
XLogP
Drug-like (Lipinski: < 5)
136
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
11
H-Bond Acceptors
958
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Sovilnesib2410796-79-9AMG-650OP393M4H32AMG 650RefChem:1076637KIF18A Inhibitor AMG 6502-(6-azaspiro(2.5)octan-6-yl)-N-(2-(4-fluoro-4-methylpiperidin-1-yl)-6-methylpyrimidin-4-yl)-4-(2-hydroxyethylsulfonylamino)benzamideAMG650AMG 650 [WHO-DD]UNII-OP393M4H32N-(2-(4,4-Difluoropiperidin-1-yl)-6-methylpyrimidin-4-yl)-4-((2-hydroxyethyl)sulfonamido)-2-(6-azaspiro[2.5]octan-6-yl)benzamideBenzamide, 2-(6-azaspiro(2.5)oct-6-yl)-N-(2-(4,4-difluoro-1-piperidinyl)-6-methyl-4-pyrimidinyl)-4-(((2-hydroxyethyl)sulfonyl)amino)-Sovilnesib(AMG-650)?orb1303452
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Sovilnesib
Loading drug network...